Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy

The introduction of chimeric antigen receptor (CAR) T-cell therapy has led to a fundamental shift in the management of relapsed and refractory large B-cell lymphoma. However, our understanding of risk factors associated with non-response is still insufficient and the search for predictive biomarkers...

詳細記述

書誌詳細

出版年:	HemaSphere
主要な著者:	Conrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, Jan-Michel Heger, Carsten Kobe, Nadine Kutsch, Peter Borchmann, Markus Dietlein, Ken Herrmann, Matthias Stelljes, Kambiz Rahbar, Georg Lenz, H. Christian Reinhardt, Marcel Teichert, Richard Noppeney, Jörn C. Albring, Robert Seifert, Bastian von Tresckow, Sarah Flossdorf, Christine Hanoun
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2023-01-01
オンライン･アクセス:	http://journals.lww.com/10.1097/HS9.0000000000000817